Crossmark

Targeted Therapy and Immune Therapy for Small Cell Lung Cancer

Crossref DOI link: https://doi.org/10.1007/s11864-018-0568-3

Published Online: 2018-09-10

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gadgeel, Shirish M.
License Information

Text and Data Mining valid from 2018-09-10
More Information

Article History

First Online: 10 September 2018

Compliance with Ethical Standards

:

: Shirish M. Gadgeel has compensation from Roche/Genentech, Bristol-Myers Squibb, AstraZeneca, AbbVie, and Ariad/Takeda for participation in advisory boards, and received support for an investigator-initiated clinical trial from Merck.

: This article does not contain any studies with human or animal subjects performed by any of the authors.